Erlotinib and Radiation Therapy for Elderly Patients with Esophageal Cancer - Clinical and Correlative Results from a Prospective Multicenter Phase 2 Trial

Publisher： Karger

E-ISSN： 1423-0232|85|1|53-58

ISSN： 0030-2414

Source： Oncology, Vol.85, Iss.1, 2013-07, pp. : 53-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intense Therapy in Patients with Locally Advanced Esophageal Cancer beyond Hope for Surgical Cure: A Prospective, Multicenter Phase II Trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)

By  

Oncology Research and Treatment, Vol. 33, Iss. 5, 2010-04 ,pp. : 222-228

Karger

Access to resources Recommend Favorite

Sequential erlotinib with gemcitabine in NSCLC

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 1, 2015-03 ,pp. : 4-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnosis, Management and Clinical Outcome of Bone Metastases in Breast Cancer Patients: Results from a Prospective, Multicenter Study

By  

Oncology, Vol. 71, Iss. 5-6, 2007-09 ,pp. : 374-381

Karger

Access to resources Recommend Favorite

Limited Predictive Value of FDG-PET for Response Assessment in the Preoperative Treatment of Esophageal Cancer: Results of a Prospective Multi-Center Trial (SAKK 75/02)

By  

Oncology Research and Treatment, Vol. 32, Iss. 12, 2009-11 ,pp. : 724-730

Karger

Access to resources Recommend Favorite

Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC)

By  

Oncology, Vol. 93, Iss. 2, 2017-05 ,pp. : 99-105

Karger

Access to resources Recommend Favorite